France· FR:60009573
PARACETAMOL/CODEINE TEVA 500 mg/30 mg, comprimé pelliculé
A medicinal product containing paracétamol + phosphate de codéine hémihydraté, registered in France by TEVA (PAYS-BAS), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- PARACÉTAMOL + PHOSPHATE DE CODÉINE HÉMIHYDRATÉ
- Manufacturer
- TEVA (PAYS-BAS)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip133400930167298plaquettes PVC-Aluminium de 16 comprimésEUR 1.72
- cip133400930167304plaquette(s) PVC-Aluminium polytéréphtalate (PET) papier avec fermeture de sécurité enfant de 16 comprimé(s)EUR 1.72
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Paracétamol + phosphate de codéine hémihydraté in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAcetaminophen and CodeineProficient Rx LP
- PolandAntidol 15Sandoz GmbH
- IrelandCo-codamol 15 mg/500 mg film-coated tabletsAzure Pharmaceuticals Ltd.
- SpainANALGIPLUS 500 mg/30 mg COMPRIMIDOS RECUBIERTOS CON PELICULAFaes Farma S.A.
- FinlandAltermolAlternova A/S
- SwedenAltermol 500 mg/30 mg TablettAlternova A/S
- GermanyAzur Compositum ScAristo Pharma Gmbh (Art 57)
- CzechiaKORYLANZentiva, k.s., Praha
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Belgium · Algocod, Dafalgan
- Cyprus · Parcoten
- Czechia · Korylan, Talvosilen Forte
- Germany · Azur Compositum Sc, Paracetamol Al Comp.
- Denmark · Kodipar, Pinex Comp
- Estonia · Algocalm, Paracetamol/Codeine Accord
- Spain · Analgiplus, Cod-Efferalgan
- Finland · Panacod, Paracetamol/Codeine Accord
- United Kingdom (Northern Ireland) · Co-Codamol, Co-Codamol Accord-Uk
- Greece · Lonalgal
- Hungary · Parcodin, Talvosilen Forte
- Ireland · Co-Codamol, Co-Tipol
- Iceland · Parkódín, Parkódín Forte
- Italy · Co Efferalgan, Codamol
- Lithuania · Cocodamol, Cocodamol Actavis
- Luxembourg · Algocod, Dafalgan
- Latvia · Co-Codamol Actavis, Paracetamol/Codeine Accord
- Malta · Codipar, Parcoten
- Netherlands · Paracetamol/Codeïne Eurogenerics, Paracetamol/Codeïnefosfaat Accord
- Norway · Altermol, Paracetamol / Codeine Phosphate Hemihydrate Accord
- Poland · Antidol, Efferalgan
- Portugal · Dol-U-Ron, Dol-U-Ron Forte
- Romania · Paradoren, Ultracod
- Sweden · Altermol, Citodon
- Slovakia · Korylan, Paramax-Cod
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f82d4d2f-b24c-4dc6-bfd8-5418d09bd766 GET /v1/drugs/f82d4d2f-b24c-4dc6-bfd8-5418d09bd766?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60009573",
"date_amm": "2018-12-05",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "PARACÉTAMOL + PHOSPHATE DE CODÉINE HÉMIHYDRATÉ",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about paracétamol + phosphate de codéine hémihydraté.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.